82 related articles for article (PubMed ID: 10394595)
1. Clinical utility in maximizing CD34+ cell count in stem cell grafts.
Burt RK
Oncologist; 1999; 4(3):265-8. PubMed ID: 10394595
[No Abstract] [Full Text] [Related]
2. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility in maximizing CD34+ cell count in stem cell grafts.
Burt RK
Stem Cells; 1999; 17(6):373-6. PubMed ID: 10606166
[TBL] [Abstract][Full Text] [Related]
4. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
5. Risk assessment in haematopoietic stem cell transplantation: stem cell source.
Urbano-Ispizua A
Best Pract Res Clin Haematol; 2007 Jun; 20(2):265-80. PubMed ID: 17448961
[TBL] [Abstract][Full Text] [Related]
6. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Klaus J; Herrmann D; Breitkreutz I; Hegenbart U; Mazitschek U; Egerer G; Cremer FW; Lowenthal RM; Huesing J; Fruehauf S; Moehler T; Ho AD; Goldschmidt H
Eur J Haematol; 2007 Jan; 78(1):21-8. PubMed ID: 17042762
[TBL] [Abstract][Full Text] [Related]
7. Rigorous administration of methotrexate and outcome of allogeneic blood stem cell transplantation.
Mehta J; Singhal S
Bone Marrow Transplant; 2007 Feb; 39(4):243-4. PubMed ID: 17211427
[No Abstract] [Full Text] [Related]
8. Importance of CD34+ cell subsets in autologous PBSC transplantation: the mulhouse experience using CD34+CD38- cells as predictive tool for hematopoietic engraftment.
Hénon PH; Sovalat H; Bourderont D
J Biol Regul Homeost Agents; 2001; 15(1):62-7. PubMed ID: 11388746
[TBL] [Abstract][Full Text] [Related]
9. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.
Allan DS; Keeney M; Howson-Jan K; Popma J; Weir K; Bhatia M; Sutherland DR; Chin-Yee IH
Bone Marrow Transplant; 2002 Jun; 29(12):967-72. PubMed ID: 12098064
[TBL] [Abstract][Full Text] [Related]
10. A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold?
Singhal S; Powles R; Treleaven J; Kulkarni S; Sirohi B; Horton C; Millar B; Shepherd V; Tait D; Saso R; Rowland A; Long S; Mehta J
Bone Marrow Transplant; 2000 Sep; 26(5):489-96. PubMed ID: 11019837
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.
Miura Y; Ueda M; Takami A; Shiobara S; Nakao S; Hess AD
Bone Marrow Transplant; 2003 Oct; 32(8):785-90. PubMed ID: 14520422
[TBL] [Abstract][Full Text] [Related]
12. Quantitative lymphocyte subset reconstitution after allogeneic hematopoietic transplantation from matched related donors with CD34+ selected PBPC grafts unselected PBPC grafts or BM grafts.
Behringer D; Bertz H; Schmoor C; Berger C; Dwenger A; Finke J
Bone Marrow Transplant; 1999 Aug; 24(3):295-302. PubMed ID: 10455369
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
[TBL] [Abstract][Full Text] [Related]
14. Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection.
Moscardó F; Sanz GF; de La Rubia J; Jiménez C; Saavedra S; Regadera A; Andreu R; García I; Plumé G; Martínez J; Martín G; Jarque I; Sanz MA
Bone Marrow Transplant; 2001 May; 27(9):983-8. PubMed ID: 11436110
[TBL] [Abstract][Full Text] [Related]
15. Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children.
Handgretinger R; Klingebiel T; Lang P; Schumm M; Neu S; Geiselhart A; Bader P; Schlegel PG; Greil J; Stachel D; Herzog RJ; Niethammer D
Bone Marrow Transplant; 2001 Apr; 27(8):777-83. PubMed ID: 11477433
[TBL] [Abstract][Full Text] [Related]
16. [Indications and limitations of purified CD34-positive cell transplantation].
Kawano Y; Takagami Y
Rinsho Ketsueki; 1999 Jun; 40(6):459-63. PubMed ID: 10422278
[No Abstract] [Full Text] [Related]
17. Transplantation of related and unrelated umbilical cord blood stem cells in Austria. Austrian Working Party for Stem Cell Transplantation. Austrian Society of Hematology and Oncology.
Schwinger W; Urban C; Lackner H; Kerbl R; Sovinz P; Gardner H; Peters C; Niederwieser D; Fink FM; Kögler G
Wien Klin Wochenschr; 1999 May; 111(9):348-53. PubMed ID: 10407995
[TBL] [Abstract][Full Text] [Related]
18. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.
Yoon DH; Sohn BS; Jang G; Kim EK; Kang BW; Kim C; Kim JE; Kim S; Lee DH; Lee JS; Park SJ; Park CJ; Huh J; Suh C
Transfusion; 2009 Sep; 49(9):1890-900. PubMed ID: 19453991
[TBL] [Abstract][Full Text] [Related]
19. CD34 stem cell top-ups without conditioning after initial haematopoietic stem cell transplantation for correction of incomplete haematopoietic and immunological recovery in severe congenital immunodeficiencies.
Booth C; Ribeil JA; Audat F; Dal-Cortivo L; Veys PA; Thrasher AJ; Davies EG; Lefrère F; Fischer A; Cavazzana-Calvo M; Gaspar HB
Br J Haematol; 2006 Nov; 135(4):533-7. PubMed ID: 17054675
[TBL] [Abstract][Full Text] [Related]
20. Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies.
Bolwell BJ; Pohlman B; Rybicki L; Sobecks R; Dean R; Curtis J; Andresen S; Koo A; Mineff V; Kalaycio M; Sweetenham JW
Bone Marrow Transplant; 2007 Sep; 40(5):437-41. PubMed ID: 17618321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
